SCHEMBL23940769

SCHEMBL23940769

CCOC(=O)c1c(C)c(O)c(C)c(CC)c1-c1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.56
ALDH1A1 P00352 4/20 0.56
HPGD P15428 3/20 0.56
SMN1; SMN2 Q16637 3/20 0.56
LMNA P02545 2/20 0.56
GAA P10253 2/20 0.56
NPSR1 Q6W5P4 2/20 0.56
KDM4E B2RXH2 2/20 0.56
NPC1 O15118 1/20 0.56
RAB9A P51151 1/20 0.56
ADORA3 P0DMS8 7/20 0.53
TDP1 Q9NUW8 1/20 0.51
GRM6 O15303 3/20 0.50
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49
CA12 O43570 1/20 0.47
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
CA7 P43166 1/20 0.47
CA9 Q16790 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23941182 0.92 MAPT (0.56) MAPTALDH1A1HPGDSMN1; SMN2LMNA
SCHEMBL23940768 0.86 MAPT (0.50) MAPTALDH1A1HPGDSMN1; SMN2LMNA
SCHEMBL25144993 0.79 MAPT (0.51) MAPTALDH1A1HPGDSMN1; SMN2LMNA
SCHEMBL23940776 0.78 MAPT (0.50) MAPTALDH1A1HPGDSMN1; SMN2LMNA
SCHEMBL23940967 0.78 ALDH1A1 (0.50) MAPTALDH1A1HPGDSMN1; SMN2LMNA
SCHEMBL23941036 0.78 MAPT (0.56) MAPTALDH1A1HPGDSMN1; SMN2LMNA
SCHEMBL23925845 0.77 ADORA3 (0.50) MAPTALDH1A1HPGDSMN1; SMN2LMNA
SCHEMBL23926181 0.77 MAPT (0.55) MAPTALDH1A1HPGDSMN1; SMN2LMNA
SCHEMBL27933356 0.76 ALDH1A1 (0.61) MAPTALDH1A1HPGDSMN1; SMN2LMNA
SCHEMBL27450086 0.74 ESR1 (0.45) SMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230117370-A1 REGIOSELECTIVE SYNTHESIS OF SUBSTITUTED COMPOUNDS OREGON STATE UNIVERSITY (US) 2023-04-20 US disclosed
WO-2021211982-A2 REGIOSELECTIVE SYNTHESIS OF SUBSTITUTED COMPOUNDS OREGON STATE UNIVERSITY (US) 2021-10-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230117370-A1 REGIOSELECTIVE SYNTHESIS OF SUBSTITUTED COMPOUNDS CYP2B6, TYR, CYP2D6 MAPT 4814/4885ALDH1A1 88/4885HPGD 683/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.